http://www.familypracticenews.com/news/child-adolescent-medicine/single-article/rsv-hospitalization-risk-greatest-among-children-less-than-1-month-old/37a14270373b3cf92ef9c13891b965c7.html
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment